Meeder Asset Management Inc. boosted its stake in Encompass Health Co. (NYSE:EHC) by 54.5% during the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 655 shares of the company’s stock after purchasing an additional 231 shares during the period. Meeder Asset Management Inc.’s holdings in Encompass Health were worth $51,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors also recently modified their holdings of the business. Eagle Bay Advisors LLC bought a new position in shares of Encompass Health in the second quarter worth $37,000. Bbva USA bought a new position in shares of Encompass Health in the second quarter worth $59,000. Jackson Creek Investment Advisors LLC bought a new position in shares of Encompass Health in the second quarter worth $224,000. CHICAGO TRUST Co NA bought a new position in shares of Encompass Health in the second quarter worth $249,000. Finally, Smith Asset Management Group LP bought a new position in shares of Encompass Health in the second quarter worth $274,000. 90.64% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Encompass Health stock opened at $76.26 on Wednesday. The stock has a 50-day moving average price of $78.51 and a 200 day moving average price of $80.14. The company has a market cap of $7.59 billion, a P/E ratio of 19.86, a P/E/G ratio of 0.99 and a beta of 1.10. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 1.43. Encompass Health Co. has a 1 year low of $60.44 and a 1 year high of $89.68.
The company also recently declared a quarterly dividend, which will be paid on Friday, October 15th. Stockholders of record on Friday, October 1st will be paid a dividend of $0.28 per share. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.47%. The ex-dividend date is Thursday, September 30th. Encompass Health’s dividend payout ratio (DPR) is presently 38.75%.
Several research analysts recently weighed in on EHC shares. Royal Bank of Canada raised their target price on Encompass Health from $102.00 to $104.00 and gave the company an “outperform” rating in a research note on Thursday, July 29th. Credit Suisse Group raised their target price on Encompass Health from $96.00 to $98.00 and gave the company an “outperform” rating in a research note on Thursday, July 29th. Deutsche Bank Aktiengesellschaft raised their target price on Encompass Health from $104.00 to $110.00 and gave the company a “buy” rating in a research note on Thursday, July 29th. Finally, Raymond James raised Encompass Health from an “outperform” rating to a “strong-buy” rating and raised their target price for the company from $95.00 to $107.00 in a research note on Monday, August 2nd. One analyst has rated the stock with a sell rating, six have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Buy” and a consensus price target of $99.88.
Encompass Health Company Profile
Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provides rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations.
Featured Story: S&P 500 Index
Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Co. (NYSE:EHC).
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.